Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP detected by a point-of-care assay: a 12-month follow-up.

Marcucci R, Gori AM, Paniccia R, Giusti B, Valente S, Giglioli C, Buonamici P, Antoniucci D, Abbate R, Gensini GF.

Circulation. 2009 Jan 20;119(2):237-42. doi: 10.1161/CIRCULATIONAHA.108.812636. Epub 2008 Dec 31.

PMID:
19118249
[PubMed - indexed for MEDLINE]
Free Article
2.

Prognostic significance of high on-clopidogrel platelet reactivity after percutaneous coronary intervention: systematic review and meta-analysis.

Aradi D, Komócsi A, Vorobcsuk A, Rideg O, Tokés-Füzesi M, Magyarlaki T, Horváth IG, Serebruany VL.

Am Heart J. 2010 Sep;160(3):543-51. doi: 10.1016/j.ahj.2010.06.004. Review.

PMID:
20826265
[PubMed - indexed for MEDLINE]
3.

Review of prasugrel for the secondary prevention of atherothrombosis.

Spinler SA, Rees C.

J Manag Care Pharm. 2009 Jun;15(5):383-95. Review.

PMID:
19496635
[PubMed - indexed for MEDLINE]
Free Article
4.

Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data.

Fox KA, Clayton TC, Damman P, Pocock SJ, de Winter RJ, Tijssen JG, Lagerqvist B, Wallentin L; FIR Collaboration.

J Am Coll Cardiol. 2010 Jun 1;55(22):2435-45. doi: 10.1016/j.jacc.2010.03.007. Epub 2010 Mar 30. Review.

PMID:
20359842
[PubMed - indexed for MEDLINE]
Free Article
5.

Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized clinical trials.

Piscione F, Piccolo R, Cassese S, Galasso G, Chiariello M.

Catheter Cardiovasc Interv. 2009 Aug 1;74(2):323-32. doi: 10.1002/ccd.22017. Review.

PMID:
19360858
[PubMed - indexed for MEDLINE]
6.

Percutaneous coronary intervention: assessing coronary vascular risk associated with bare-metal and drug-eluting stents.

Spinler SA.

Am J Manag Care. 2009 Mar;15(2 Suppl):S42-7. Review.

PMID:
19355808
[PubMed - indexed for MEDLINE]
Free Article
7.

Critical review of prasugrel for formulary decision makers.

Schafer JA, Kjesbo NK, Gleason PP.

J Manag Care Pharm. 2009 May;15(4):335-43. Review.

PMID:
19422273
[PubMed - indexed for MEDLINE]
Free Article
8.

Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.

Motovska Z, Kala P.

Clin Ther. 2008;30 Pt 2:2191-202. doi: 10.1016/j.clinthera.2008.12.001. Review.

PMID:
19281914
[PubMed - indexed for MEDLINE]
9.

Drug-eluting stents and antiplatelet resistance.

Simon DI, Jozic J.

Am J Cardiol. 2008 Nov 3;102(9 Suppl):29J-37J. doi: 10.1016/j.amjcard.2008.09.007. Review.

PMID:
18928790
[PubMed - indexed for MEDLINE]
10.

Antiplatelet therapy in percutaneous coronary intervention: integration of prasugrel into clinical practice.

Thomas D, Giugliano RP.

Crit Pathw Cardiol. 2009 Mar;8(1):12-9. doi: 10.1097/HPC.0b013e318196bb46. Review.

PMID:
19258833
[PubMed - indexed for MEDLINE]
11.

Role of prasugrel, a novel P2Y(12) receptor antagonist, in the management of acute coronary syndromes.

Baker WL, White CM.

Am J Cardiovasc Drugs. 2009;9(4):213-29. doi: 10.2165/1131209-000000000-00000. Review.

PMID:
19655817
[PubMed - indexed for MEDLINE]
12.

Meta-analysis appraising high clopidogrel loading in patients undergoing percutaneous coronary intervention.

Lotrionte M, Biondi-Zoccai GG, Agostoni P, Abbate A, Angiolillo DJ, Valgimigli M, Moretti C, Meliga E, Cuisset T, Alessi MC, Montalescot G, Collet JP, Di Sciascio G, Waksman R, Testa L, Sangiorgi G, Laudito A, Trevi GP, Sheiban I.

Am J Cardiol. 2007 Oct 15;100(8):1199-206. Epub 2007 Jul 30. Review.

PMID:
17920357
[PubMed - indexed for MEDLINE]
13.

Optimizing antiplatelet therapy for the ACS patient: reacting to clinical trial data from the ISAR-REACT-2 studies.

Steinhubl SR.

Rev Cardiovasc Med. 2006;7 Suppl 4:S12-9. Review.

PMID:
17224886
[PubMed - indexed for MEDLINE]
14.

The problem with composite end points in cardiovascular studies: the story of major adverse cardiac events and percutaneous coronary intervention.

Kip KE, Hollabaugh K, Marroquin OC, Williams DO.

J Am Coll Cardiol. 2008 Feb 19;51(7):701-7. doi: 10.1016/j.jacc.2007.10.034. Review.

PMID:
18279733
[PubMed - indexed for MEDLINE]
Free Article
15.

[Care of patients after coronary stent implantation: what is important in practice?].

Schächinger V.

Internist (Berl). 2007 Dec;48(12):1365-74. Review. German.

PMID:
17992495
[PubMed - indexed for MEDLINE]
16.

Antiplatelet therapy in the treatment of atherothrombotic disease: considering the evidence.

Aronow WS.

Geriatrics. 2007 Apr;62(4):12-24. Review.

PMID:
17408314
[PubMed - indexed for MEDLINE]
17.

Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologists.

Angiolillo DJ, Suryadevara S, Capranzano P, Zenni MZ, Guzman LA, Bass TA.

Catheter Cardiovasc Interv. 2009 Jan 1;73(1):1-14. doi: 10.1002/ccd.21782. Review.

PMID:
19089929
[PubMed - indexed for MEDLINE]
18.

The use of the VerifyNow system to monitor antiplatelet therapy: a review of the current evidence.

van Werkum JW, Harmsze AM, Elsenberg EH, Bouman HJ, ten Berg JM, Hackeng CM.

Platelets. 2008 Nov;19(7):479-88. doi: 10.1080/09537100802317918. Review.

PMID:
18979359
[PubMed - indexed for MEDLINE]
19.

Latest clinical data on testing for high on-treatment platelet reactivity.

Fileti L, Campo G, Valgimigli M.

Rev Cardiovasc Med. 2011;12 Suppl 1:S14-22. Review.

PMID:
22080983
[PubMed - indexed for MEDLINE]
20.

Acute coronary syndrome in the patient with diabetes: is the management different?

Amin AP, Marso SP.

Curr Cardiol Rep. 2010 Jul;12(4):321-9. doi: 10.1007/s11886-010-0118-5. Review.

PMID:
20446120
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk